Antimicrobial resistance (AMR) is a significant global health crisis, affecting human, animal, and environmental health. Addressing this urgent issue requires a coordinated "One Health" approach and innovative solutions, such as genomics.

Genomics is an increasingly important tool in understanding the mechanisms of AMR and developing effective strategies for control. It has revolutionized our understanding of AMR by providing insights into the genetic mechanisms of resistance, helping track the spread across different strains and geographic locations.

By leveraging the power of genomics, Illumina is advancing the One Health approach and promoting global health security in the fight against AMR. Attend this webinar to understand how genomic analysis offers new opportunities for prediction and surveillance of AMR and how this information can be used to mitigate its spread.

The three key things you will learn include:

• Introduction to Illumina BaseSpace Sequencing Hub (BSSH) for analysis, storage and sharing of genomic data, including SRST2 app for rapid genomic surveillance.
• Understand the Illumina Urinary Pathogen ID/AMR Panel (UPIP) product features, including recommended technical specifications and data analysis using the complimentary Explify UPIP Data Analysis app available on BSSH.
• Understand the Illumina DNA prep for preparation of microbial whole genome sequencing. 

Speaker:

Zhiliang Chen Executive Bioinformatics Sales Specialist, Illumina Zhiliang holds a bachelor and a PhD in bioinformatics. During the years working with NGS data, she has extensive experience in different types of NGS data analysis, including genome and transcriptome analysis on various species, from bacteria, insects to mammals.

Nurdyana Abdul Rahman Sr Technical Application Scientist, Illumina Nurdyana graduated from the University of Queensland with a PhD in Microbial genomics and ecology. She worked for a Sequencing Service provider as a Research Assistant. By handling the Illumina NGS platforms, she gained practical experience with Illumina’s Next Generation Sequencing technology during her employment. She then moved to a Hospital Microbiology laboratory as a Medical Lab Scientist, where she was responsible for overseeing the epidemiology section and setting up NGS in clinical microbiology to assist in outbreak investigations. Nurdyana joined Illumina as a Sr Technical Applications Scientist in February 2022 to provide analysis software and bioinformatics technical support.

View all the webinars in the Illumina One Health and Sustained Pathogen Surveillance Webinar Series.